Statin use and cancer risk in the General Practice Research Database

被引：0
作者：
J A Kaye
H Jick
机构：
[1] Boston Collaborative Drug Surveillance Program,
[2] Boston University School of Medicine,undefined
来源：
British Journal of Cancer | 2004年 / 90卷
关键词：
3-hydroxy-3-methylglutaryl coenzyme A inhibitors; statins; hyperlipidaemia; epidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In a matched case–control study using the General Practice Research Database, current statin use was not associated with a significantly altered risk of any of 13 studied cancers. Untreated hyperlipidaemia was associated with slightly increased risks of colon cancer (relative risk 1.8; 95% confidence interval 1.2–2.8), prostate cancer (1.5; 1.1–2.0), and bladder cancer (1.9; 1.2–3.1).
引用
收藏
页码：635 / 637
页数：2
相关论文
共 107 条
[1]  
Alonso DF(1998)Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis Breast Cancer Res Treat 50 83-93
[2]  
Farina HG(2003)Statin use and the risk of breast cancer J Clin Epidemiol 56 280-285
[3]  
Skilton G(2001)Do statins cause cancer? A meta-analysis of large randomized clinical trials Am J Med 110 716-723
[4]  
Gabri MR(2000)3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer. A nested case–control study Arch Intern Med 160 2363-2368
[5]  
De Lorenzo MS(2002)Statin use and the risk of breast and prostate cancer Epidemiology 13 262-267
[6]  
Gomez DE(2002)Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas Neoplasia 4 337-346
[7]  
Beck P(1997)Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials JAMA 278 313-321
[8]  
Wysowski KD(1991)Validation of information recorded on general practitioner based computerized data resource in the United Kingdom BMJ 302 766-768
[9]  
Downey W(1997)Calcium-channel blockers and risk of cancer Lancet 349 525-528
[10]  
Butler-Jones D(2003)Validity of the General Practice Research Database Pharmacotherapy 23 686-689
12345678910